TETRABUTYLAMMONIUM TETRATHIORHENATE (VII)

Modify Date: 2024-01-04 15:47:58

TETRABUTYLAMMONIUM TETRATHIORHENATE (VII) Structure
TETRABUTYLAMMONIUM TETRATHIORHENATE (VII) structure
Common Name TETRABUTYLAMMONIUM TETRATHIORHENATE (VII)
CAS Number 16829-47-3 Molecular Weight 465.86600
Density N/A Boiling Point N/A
Molecular Formula C21H39NS5 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name Tetrabutylammonium tetrathiorhenate(VII), 99%
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C21H39NS5
Molecular Weight 465.86600
Exact Mass 465.16900
PSA 104.65000
LogP 8.30510

 MSDS


Section 1: Product Identification
Chemical Name:Tetrabutylammonium tetrathiorhenate (VII), 99%
CAS Registry Number:16829-47-3
Formula:(C4H9)4NReS4
EINECS Number:none
Chemical Family:metal sulfide
Synonym:none

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound16829-47-3100%no datano data

Section 3: Hazards Identification
Emergency Overview:Irritating to the respiratory tract, skin and eyes. May be harmful if swallowed.
Primary Routes of Exposure:Ingestion, inhalation
Eye Contact:Causes slight to mild irritation of the eyes.
Skin Contact:Causes slight to mild irritation of the skin.
Inhalation:Irritating to skin, eyes and respiratory tract.
Ingestion:No information is available on the physiological effects of ingestion
Acute Health Affects:Irritating to skin, eyes and respiratory tract.
Chronic Health Affects:No information available on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in
Inhalation:
breathing, coughing, wheezing or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:no data
Autoignition Temperature:no data
Explosion Limits:no data
Extinguishing Medium:carbon dioxide, dry chemical or foam
If this product is involved in a fire, firefighters should be equipped with NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit irritating rhenium oxide fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be mixed with sodium carbonate or vermiculite and swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a cool, dry well-ventilated area away from heat and direct sunlight. Keep containers tightly sealed.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothing and gloves.
Ventilation:This product should be handled in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respiratory
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:This product should be handled in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:black xtl.
Molecular Weight:556.94
Melting Point:no data
Boiling Point:no data
Vapor Pressure:no data
Specific Gravity:no data
Odor:none
Solubility in Water:soluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable
Hazardous Polymerization:no hazardous polymerization.
Conditions to Avoid:none
Incompatibility:oxidizing agents
Decomposition Products:carbon monoxide, carbon dioxide, nitrogen oxides, sulfur dioxide, rhenium oxide and organic fumes.

SECTION 11: Toxicological Information
RTECS Data:No information available in RTECS.
Carcinogenic Effects:no data
Mutagenic Effects:no data
Tetratogenic Effects:no data

SECTION 12: Ecological Information
Ecological Information:No information available.

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Not listed in the TSCA inventory.
SARA (Title 313):Title compound not listed.
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

Tetrabutylammonium tetrathiorhenate
Top Suppliers:I want be here


Get all suppliers and price by the below link:

TETRABUTYLAMMONIUM TETRATHIORHENATE (VII) suppliers

TETRABUTYLAMMONIUM TETRATHIORHENATE (VII) price

Related Compounds: More...
TETRABUTYLAMMONIUM TETRATHIORHENATE (VII)
99459-09-3
Tetrabutylammonium chlorochromate
54712-57-1
Tetrabutylammonium di-tert-butyl phosphate
68695-48-7
TETRABUTYLAMMONIUM TETRACHLOROOXORHENATE(V)
53675-30-2
TETRABUTYLAMMONIUM TETRACHLOROGALLATE (&
38555-81-6
tetrabutylammonium tribromocarbonylplatinate
87793-14-4
tetrabutylammonium stearate
60080-83-3
Tetrabutylammonium Hydrogen Sulfide
84030-21-7
Tetrabutylammonium cyanoborohydride
43064-96-6
2-Cyclobutyl-7-(cyclopropylmethyl)-[1,2,4]triazolo[1,5-a]pyridin-5-ol
2137611-35-7
(2S,5R,5aS,7R,11S)-3,4,5,5a-Tetrahydro-2-(1-hydroxy-1-methylethyl)-5-methyl-7,9,11-tris(3-methyl-2-buten-1-yl)-5a-(2-methyl-1-oxopropyl)-5,7-ethano-1-benzoxepin-6,8(2H,7H)-dione
262857-89-6
1,3-Dioxane-4-acetic acid, 6-[2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)-rel-
1379976-09-6
1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, 2-hydroxy-1,3-propanediyl ester, [1R-[1I+/-(1R*,4aR*,4bR*,10aR*),4aI(2),4bI+/-,10aI+/-]]-
157615-82-2
(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]-hydroxyamino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
1644461-92-6
(4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12-pentahydroxy-6-methyl-1,11-dioxo-12a-[[(phenylamino)carbonyl]oxy]-2-naphthacenecarboxamide
121355-89-3
1-(Ethoxycarbonyl)-4,4-dimethylcyclohexane-1-carboxylic acid
2137799-37-0
1-[2-(Propane-2-sulfonyl)ethyl]cyclopropane-1-sulfonyl chloride
2003146-50-5
N1,N3-Bis(aminoiminomethyl)-6-O-[(4S,5R,6S,8R,9R)-9-[[2-deoxy-2-(methylamino)-I+/--L-glucopyranosyl]oxy]-4-hydroxy-6-methyl-2-oxo-1,7-dioxa-3-azaspiro[4.4]non-8-yl]-D-streptamine
1010401-11-2
(1R,5S)-1,2,3,4,5,6-Hexahydro-3-[10-[(1R,5S)-1,5,6,8-tetrahydro-8-oxo-1,5-methano-2H-pyrido[1,2-a][1,5]diazocin-3(4H)-yl]decyl]-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one
121098-54-2